Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Foresight firms agree to sell stakes in Lunanhead battery project

(Sharecast News) - Foresight Environmental Infrastructure and Foresight Solar Fund announced on Wednesday that they have agreed to sell their 50% stakes in the 50MW Lunanhead battery energy storage project in Perthshire, Scotland, with the deal expected to close later this quarter. Both companies said the sale price was in line with the asset's carrying value as at 30 June, and reflected their capital allocation strategies, under which proceeds were being weighed against options including share buybacks and debt reduction.

Each also holds a 50% stake in the Clayfords battery project, for which strategic options remained under review.

In a further update, the companies confirmed that the jointly owned 50MW Sandridge battery project in Wiltshire had now been energised and entered its final commissioning phase, with commercial operations expected shortly.

Foresight Environmental Infrastructure said Sandridge would become its second operational battery storage asset, joining West Gourdie in supporting renewable energy integration and grid stability, while Foresight Solar said the project would help underpin future income growth as its storage portfolio develops.

At 1001 BST, shares in Foresight Environmental Infrastructure were down 0.48% at 80.01p, while those in Foresight Solar were up 0.8% at 82.25p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.